Finance

Lists
LFST:NASDAQ
Lifestance Health Group Inc
$13.00
+3.01%
(+0.38) 1D
$13.11
+0.85% (+0.11)
Pre-market
Closed: Sep 10, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LFST...
Open
$12.60
High
$13.26
Low
$12.60
Mkt. cap
4.97B
Avg. vol.
4.34M
Volume
3.23K
P/E ratio
101.23
52-wk high
$13.26
52-wk low
$4.78
EPS
$0.13
Beta
1.22
Shares outstanding
382.06M
No. of employees
9K
Open
$12.60
High
$13.26
Low
$12.60
Mkt. cap
4.97B
Avg. vol.
4.34M
Volume
3.23K
P/E ratio
101.23
52-wk high
$13.26
52-wk low
$4.78
EPS
$0.13
Beta
1.22
Shares outstanding
382.06M
No. of employees
9K
News stories
From web sources and news partners
Profile
Lifestance Health is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors. Wikipedia
About Lifestance Health Group Inc
CEO-
Employees8.54K
Founded2015
HeadquartersScottsdale, Arizona, United States
SectorHealth care provider
Websitelifestance.com
Analyst ratings
Based on 9 analysts giving stock ratings to LFST in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for LFST in the last 3 months.
Highest
Current $13.00
$18.00 (+38.46%)
Average
$14.25 (+9.62%)
Lowest
$13.00 (0.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Peter Warendorf
Barclays
Buy
Maintained
$15.00
+15.4%
09/10/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
$15.00
+15.4%
09/09/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
08/21/2026
David Larsen
BTIG
Buy
Maintained
$18.00
+38.5%
08/19/2026
Lisa Gill
J.P. Morgan
Hold
Maintained
$13.00
0%
08/14/2026
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
$13.00
0%
08/12/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$13.00
0%
08/06/2026
Jack Slevin
Jefferies
Buy
Maintained
$14.00
+7.7%
07/16/2026
Unknown Analyst
Jefferies
Buy
Maintained
$14.00
+7.7%
07/16/2026
Steve Dechert
KeyBanc
Buy
Maintained
$13.00
0%
07/13/2026
Scott Fidel
Goldman Sachs
Hold
Initiated
$9.00
-30.8%
06/05/2026
Kevin Caliendo
UBS
Buy
Maintained
$13.00
0%
05/08/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.11 / $0.08
+32.41%beat
Revenue / Est. (USD)
435.35M / 414.53M
+5.02%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
363.81M
382.20M
403.48M
435.35M
Cost of goods sold
247.23M
255.90M
267.54M
282.31M
Cost of revenue
247.23M
255.90M
267.54M
282.31M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95.69M
94.74M
100.24M
107.23M
Operating expense
109.25M
108.18M
113.56M
121.48M
Total operating expenses
356.48M
364.08M
381.11M
403.79M
Operating income
7.33M
18.12M
22.37M
31.56M
Other non operating income
-24.00K
-6.00K
-182.00K
-93.00K
EBT including unusual items
4.57M
15.20M
19.76M
27.46M
EBT excluding unusual items
4.50M
15.24M
20.40M
28.84M
Income tax expense
3.50M
3.54M
5.52M
3.84M
Effective tax rate
76.44%
23.25%
27.92%
14.00%
Other operating expenses
-
-
-
-
Net income
1.08M
11.67M
14.24M
23.61M
Net profit margin
0.30%
3.05%
3.53%
5.42%
Earnings per share
0.01
0.09
0.07
0.11
Interest and investment income
-
-
-
-
Interest expense
-2.81M
-2.88M
-1.79M
-2.63M
Net interest expenses
-2.81M
-2.88M
-1.79M
-2.63M
Depreciation and amortization charges
13.56M
13.43M
13.32M
14.25M
EBITDA
20.89M
31.55M
35.69M
45.81M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps